Stem Cells http://www.peprotech.com/
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online February 23, 2006
Stem Cells Vol. 24 No. 6 June 2006, pp. 1620 -1626
doi:10.1634/stemcells.2005-0365; www.StemCells.com
© 2006 AlphaMed Press

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2005-0365v1
24/6/1620    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, S.-W.
Right arrow Articles by Kang, K.-S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, S.-W.
Right arrow Articles by Kang, K.-S.

research-article

Successful Stem Cell Therapy Using Umbilical Cord Blood-Derived Multipotent Stem Cells for Buerger’s Disease and Ischemic Limb Disease Animal Model

Sung-Whan Kima, Hoon Hanb, Gue-Tae Chaea, Sung-Hoon Leec, Sun Boc, Jung-Hee Yoond, Yong-Soon Leec, Kwang-Soo Leee, Hwon-Kyum Parke, Kyung-Sun Kangc

a Department of Pathology, College of Medicine, The Catholic University, Seoul, Korea;
b The Seoul Cord Bank, Histostem Co., Ltd, Seoul, Korea;
c Laboratory of Stem Cell and Tumor Biology, Department of Veterinary Public Health,
d Department of Veterinary Radiology, College of Veterinary Medicine, Seoul National University, Seoul, Korea;
e Department of Surgery, College of Medicine, Hanyang University, Seoul, Korea

Key Words. Cord blood • Mesenchymal stem cells • Buerger’s disease • Cell transplantation

Correspondence: Kyung-Sun Kang, Ph.D., Laboratory of Stem Cell and Tumor Biology, Department of Veterinary Public Health, College of Veterinary Medicine, Seoul National University, Seoul, Korea. Telephone: 82-2-880-1246; Fax: 82-2-876-7610; e-mail: kangpub{at}snu.ac.kr; Hwon-Kyum Park, M.D., Ph.D., Department of Surgery, College of Medicine, Hanyang University, Seoul, Korea. Telephone: 82-31-560-2290; Fax: 82-31-566-4409; e-mail: hkpark{at}hanyang.ac.kr

Received August 4, 2005; accepted for publication February 15, 2006.

Buerger’s disease, also known as thromboangiitis obliterans, is a nonatherosclerotic, inflammatory, vasoocclusive disease. It is characterized pathologically as a panangiitis of medium and small blood vessels, including both arteries and adjacent veins, especially the distal extremities (the feet and the hands). There is no curative medication or surgery for this disease. In the present study, we transplanted human leukocyte antigen-matched human umbilical cord blood (UCB)-derived mesenchymal stem cells (MSCs) into four men with Buerger’s disease who had already received medical treatment and surgical therapies. After the stem cell transplantation, ischemic rest pain suddenly disappeared from their affected extremities. The necrotic skin lesions were healed within 4 weeks. In the follow-up angiography, digital capillaries were increased in number and size. In addition, vascular resistance in the affected extremities, compared with the preoperative examination, was markedly decreased due to improvement of the peripheral circulation. Because an animal model of Buerger’s disease is absent and also to understand human results, we transplanted human UCB-derived MSCs to athymic nude mice with hind limb ischemia by femoral artery ligation. Up to 60% of the hind limbs were salvaged in the femoral artery-ligated animals. By in situ hybridization, the human UCB-derived MSCs were detected in the arterial walls of the ischemic hind limb in the treated group. Therefore, it is suggested that human UCB-derived MSC transplantation may be a new and useful therapeutic armament for Buerger’s disease and similar ischemic diseases.




This article has been cited by other articles:


Home page
Stem CellsHome page
S. Ishikane, S. Ohnishi, K. Yamahara, M. Sada, K. Harada, K. Mishima, K. Iwasaki, M. Fujiwara, S. Kitamura, N. Nagaya, et al.
Allogeneic Injection of Fetal Membrane-Derived Mesenchymal Stem Cells Induces Therapeutic Angiogenesis in a Rat Model of Hind Limb Ischemia
Stem Cells, October 1, 2008; 26(10): 2625 - 2633.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
K. C. Partlow, J. Chen, J. A. Brant, A. M. Neubauer, T. E. Meyerrose, M. H. Creer, J. A. Nolta, S. D. Caruthers, G. M. Lanza, and S. A. Wickline
19F magnetic resonance imaging for stem/progenitor cell tracking with multiple unique perfluorocarbon nanobeacons
FASEB J, June 1, 2007; 21(8): 1647 - 1654.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
X. Puechal and J.-N. Fiessinger
Thromboangiitis obliterans or Buerger's disease: challenges for the rheumatologist
Rheumatology, February 1, 2007; 46(2): 192 - 199.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
Q. He, C. Wan, and G. Li
Concise Review: Multipotent Mesenchymal Stromal Cells in Blood
Stem Cells, January 1, 2007; 25(1): 69 - 77.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS

Copyright © 2006 by AlphaMed Press.